Literature DB >> 12967284

Selective monoacylation of symmetrical diamines via prior complexation with boron.

Zhongxing Zhang1, Zhiwei Yin, Nicholas A Meanwell, John F Kadow, Tao Wang.   

Abstract

[reaction: see text] Pretreatment of a symmetrical primary or secondary diamine with 9-BBN prior to the addition of an acyl chloride significantly suppressed undesired diacylation, and the product of monoacylation predominated. The reactive preference is interpreted as the result of a selective deactivation of one nitrogen atom of the diamine by 9-BBN.

Entities:  

Year:  2003        PMID: 12967284     DOI: 10.1021/ol0300773

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  4 in total

1.  Diamine Derivatives as Novel Small-Molecule, Potent, and Subtype-Selective Somatostatin SST3 Receptor Agonists.

Authors:  Derun Li; Zhicai Wu; Yang Yu; Richard G Ball; Liangqin Guo; Edward Sherer; Shuwen He; Qingmei Hong; Zhong Lai; Hongbo Qi; Quang Truong; David X Yang; Gary G Chicchi; Kwei-Lan Tsao; Dorina Trusca; Maria Trujillo; Michele Pachanski; George J Eiermann; Andrew D Howard; Yun-Ping Zhou; Bei B Zhang; Ravi P Nargund; William K Hagmann
Journal:  ACS Med Chem Lett       Date:  2014-04-24       Impact factor: 4.345

2.  Symmetrical and unsymmetrical alpha,omega-nucleobase amide-conjugated systems.

Authors:  Sławomir Boncel; Maciej Maczka; Krzysztof K K Koziol; Radosław Motyka; Krzysztof Z Walczak
Journal:  Beilstein J Org Chem       Date:  2010-04-12       Impact factor: 2.883

3.  Highly selective acylation of polyamines and aminoglycosides by 5-acyl-5-phenyl-1,5-dihydro-4H-pyrazol-4-ones.

Authors:  Kostiantyn O Marichev; Estevan C Garcia; Kartick C Bhowmick; Daniel J Wherritt; Hadi Arman; Michael P Doyle
Journal:  Chem Sci       Date:  2017-08-30       Impact factor: 9.825

Review 4.  Innovation in the discovery of the HIV-1 attachment inhibitor temsavir and its phosphonooxymethyl prodrug fostemsavir.

Authors:  Tao Wang; John F Kadow; Nicholas A Meanwell
Journal:  Med Chem Res       Date:  2021-09-28       Impact factor: 1.965

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.